CTLT - Catalent's Activist Board Presence To Boost Operational Recovery Analyst Says | Benzinga
Tuesday, Catalent Inc (NYSE: CTLT) reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the consensus of $1.05 billion.
The company forecasts FY24 sales of $4.30 billion-$4.50 billion versus the consensus of $4.21 billion and $4.28 billion in FY23.
The company also finalized a deal with activist investor Elliott Investment Management.
William Blair analysts Max Smock and Christine Rains write that activist presence on Catalent board and creating the strategic review committee will speed up the company's operational ...